Claude R. Benedict

10.2k total citations · 3 hit papers
112 papers, 8.1k citations indexed

About

Claude R. Benedict is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Claude R. Benedict has authored 112 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cardiology and Cardiovascular Medicine, 25 papers in Molecular Biology and 22 papers in Surgery. Recurrent topics in Claude R. Benedict's work include Heart Failure Treatment and Management (19 papers), Cardiovascular Function and Risk Factors (17 papers) and Cardiac electrophysiology and arrhythmias (11 papers). Claude R. Benedict is often cited by papers focused on Heart Failure Treatment and Management (19 papers), Cardiovascular Function and Risk Factors (17 papers) and Cardiac electrophysiology and arrhythmias (11 papers). Claude R. Benedict collaborates with scholars based in United States, Japan and Canada. Claude R. Benedict's co-authors include Salim Yusuf, Rajbabu Pakala, David E. Johnstone, Gary S. Francis, Samir Kapadia, Hakan Oral, Douglas L. Mann, Guillermo Torre‐Amione, John M. Nicklas and Philip C. Kirlin and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Claude R. Benedict

107 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).

1990 1.1k citations Gary S. Francis, Claude R. Benedict et al. Circulation profile →
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

1996 974 citations Guillermo Torre‐Amione, Samir Kapadia et al. Journal of the American College of Cardiology profile →
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1992 489 citations Salim Yusuf, H. Pouleur et al. profile →

Peers

Countries citing papers authored by Claude R. Benedict

Since Specialization

Citations

This map shows the geographic impact of Claude R. Benedict's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude R. Benedict with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude R. Benedict more than expected).

Fields of papers citing papers by Claude R. Benedict

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude R. Benedict. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude R. Benedict. The network helps show where Claude R. Benedict may publish in the future.

Co-authorship network of co-authors of Claude R. Benedict

This figure shows the co-authorship network connecting the top 25 collaborators of Claude R. Benedict. A scholar is included among the top collaborators of Claude R. Benedict based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude R. Benedict. Claude R. Benedict is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rate of Osteoporosis Evaluation and Treatment Following Kyphoplasty in Patients With Vertebral Compression Fractures: A Retrospective Study and Review of the Literature 2025 ·Geriatric Orthopaedic Surgery & Rehabilitation ·Claude R. Benedict, (unknown), (unknown), (unknown), Edward Fox	0
2	The high-fat high-fructose hamster as an animal model for niacin’s biological activities in humans 2013 ·Metabolism ·Beth A. Connolly, (unknown), Stefania Lamon‐Fava, (unknown), Yu‐Lin Kuang, Ernst J. Schaefer, (unknown), Claude R. Benedict, Christopher P. Kiritsy, William W. Bachovchin	6
3	Abstract 18285: ARI-3037MO, a Novel Niacin Analog, Significantly Improves Plasma Lipid Levels in the Hyperlipidemic Golden Syrian Hamster 2011 ·Circulation ·Beth A. Connolly, (unknown), (unknown), Yu‐Lin Kuang, Ernst J. Schaefer, Stefania Lamon‐Fava, Claude R. Benedict, Christopher P. Kiritsy, William W. Bachovchin	2
4	Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation 2002 ·Journal of the American College of Cardiology ·Takuya Watanabe, Takashi Katagiri, Rajbabu Pakala, Claude R. Benedict	1
5	Antioxidant N-acetylcysteine inhibits vasoactive agents potentiated mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells 2002 ·Journal of the American College of Cardiology ·Takuya Watanabe, Takashi Katagiri, Rajbabu Pakala, Claude R. Benedict	1
6	Angiotensin II and serotonin potentiate endothelin-1-induced vascular smooth muscle cell proliferation 2001 ·Journal of Hypertension ·Takuya Watanabe, Rajbabu Pakala, Takashi Katagiri, Claude R. Benedict	38
7	Synergistic interaction between thromboxane A2and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation 2000 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Satoshi Koba, Rajbabu Pakala, Takuya Watanabe, Takashi Katagiri, Claude R. Benedict	19
8	Modulation of endothelial cell proliferation by retinoid x receptor agonists 1999 ·European Journal of Pharmacology ·Rajbabu Pakala, Claude R. Benedict	1
9	Thromboxane A2fails to induce proliferation of smooth muscle cells enriched with eicosapentaenoic acid and docosahexaenoic acid 1999 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Rajbabu Pakala, (unknown), Claude R. Benedict	6
10	Vascular smooth muscle proliferation 1999 ·Journal of the American College of Cardiology ·Shinji Koba, Rajbabu Pakala, Takuya Watanabe, Takashi Katagiri, Claude R. Benedict	28
11	Endothelial cells regulate the proliferation of monocytes in vitro 1999 ·Atherosclerosis ·Rajbabu Pakala, Claude R. Benedict	8
12	Effect of serotonin and throm☐ane A2 on endothelial cell proliferation: Effect of specific receptor antagonists 1998 ·Journal of Laboratory and Clinical Medicine ·(unknown), Claude R. Benedict	37
13	Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction 1996 ·The American Journal of Cardiology ·Chris Koilpillai, Miguel A. Quiñones, Barry Greenberg, Marian C. Limacher, Daniel M. Shindler, Craig M. Pratt, Claude R. Benedict, Helen A. Kopelen, Brent J. Shelton, The SOLVD Investigators	49
14	Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group. 1996 ·Journal of Clinical Oncology ·Paul J. Hesketh, Rudolph M. Navari, Thomas Grote, Richard J. Gralla, John D. Hainsworth, Mark G. Kris, Anthony Le Bras, Ali Khojasteh, Efstathios Tapazoglou, Claude R. Benedict, William F. Hahne	111
15	Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD) breakdown → 1996 ·Journal of the American College of Cardiology ·Guillermo Torre‐Amione, Samir Kapadia, Claude R. Benedict, Hakan Oral, (unknown), Douglas L. Mann	974
16	Neurohumoral variability in left ventricular dysfunction 1995 ·The American Journal of Cardiology ·Philip C. Kirlin, Claude R. Benedict, Brent J. Shelton, Gary S. Francis, John M. Nicklas, Chang‐seng Liang, Spencer H. Kubo, David E. Johnstone, Jeffrey L. Probstfield, Salim Yusuf	8
17	Neurohormones in patients with ischemic left ventricular dysfunction 1994 ·Cardiovascular Drugs and Therapy ·H. Pouleur, Claude R. Benedict, Michel F. Rousseau	4
18	Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the studies of left ventricular dysfunctions (SOLVD) registry 1993 ·Journal of the American College of Cardiology ·Claude R. Benedict, Debra H. Weiner, David E. Johnstone, Martial G. Bourassa, Jalal K. Ghali, John M. Nicklas, Philip C. Kirlin, Barry Greenberg, Miguel A. Quiñones, Salim Yusuf	116
19	Effects of graded oxygen tension on adenosine release by renal medullary and thick ascending limb suspensions 1991 ·Kidney International ·Robert E. Beach, Bruns A. Watts, David W. Good, Claude R. Benedict, Thomas D. DuBose	31
20	Relationship between neurohumoral activation, severity of left ventricular dysfunction (LVD) and clinical status 1991 ·Journal of the American College of Cardiology ·Claude R. Benedict, David E. Johnstone, Martial G. Bourassa, Vera Bittner, (unknown), Barry Greenberg, Richard Kay, Philip C. Kirlin, Robert M. Kohn, Kevin McIntyre, Melvin B. Weiss, (unknown), Salim Yusuf	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact